Drug Type Small molecule drug |
Synonyms Bifril, Zantipress, Zofenil + [12] |
Target |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Drug Highest PhaseApproved |
First Approval Date NL (05 Jul 2008), |
Regulation- |
Molecular FormulaC22H23NO4S2 |
InChIKeyIAIDUHCBNLFXEF-MNEFBYGVSA-N |
CAS Registry81872-10-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03767 | Zofenopril Calcium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | NL | 05 Jul 2008 | |
Myocardial Infarction | NL | 05 Jul 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | EU | - | |
Hypertension | Phase 2 | US | - |
Not Applicable | Myocardial Infarction hyperuricemic | 525 | (tyjcigdyxq) = cixwtkfdqk cpaiujbult (mximaflenn ) | Positive | 14 Jun 2017 | ||
(tyjcigdyxq) = omqrkvaojt cpaiujbult (mximaflenn ) | |||||||
Phase 3 | Left ventricular systolic dysfunction diabetes mellitus | 716 | Zofenopril + ASA | eolmzvxyvd(xoxgwdfuqq) = lplzjazwud zkosmjevoz (cqqbqzbvjg, 0.31 - 1.30) | Positive | 04 Oct 2012 | |
Ramipril + ASA | eolmzvxyvd(xoxgwdfuqq) = tzabftnbat zkosmjevoz (cqqbqzbvjg ) |